Redwood City, CA, United States of America

Liza Huijse

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Karius, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liza Huijse. Retrieved from https://idiyas.com/inventor/liza-huijse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liza Huijse: Innovator in Nucleic Acid Detection

Introduction

Liza Huijse is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of nucleic acid detection, particularly in differentiating between target and contaminant nucleic acids. Her work is crucial for clinical applications, ensuring accurate diagnostics.

Latest Patents

Liza holds a patent for a method titled "Sample series to differentiate target nucleic acids from contaminant nucleic acids." This patent provides innovative methods, compositions, and kits designed to determine whether nucleic acids detected in clinical samples are derived from contaminant pathogens or clinically relevant pathogens. She has 1 patent to her name.

Career Highlights

Liza is currently employed at Karius, Inc., a company that focuses on advancing diagnostic technologies. Her role at Karius allows her to apply her expertise in nucleic acid detection to develop solutions that enhance patient care.

Collaborations

Liza has collaborated with notable colleagues, including Timothy A Blauwkamp and Michael Rosen. These partnerships have contributed to her innovative work and the advancement of diagnostic methodologies.

Conclusion

Liza Huijse is a dedicated inventor whose work in nucleic acid detection is paving the way for improved clinical diagnostics. Her contributions are vital for the medical field, ensuring that accurate and reliable testing methods are available.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…